Lucas A Hill
Overview
Explore the profile of Lucas A Hill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheema J, Mathews W, Wynn A, Bamford L, Torriani F, Hill L, et al.
Open Forum Infect Dis
. 2023 Apr;
10(4):ofad153.
PMID: 37065984
Background: Rising incidence of hepatitis C virus (HCV) among people with HIV (PWH) in San Diego County (SDC) was reported. In 2018, the University of California San Diego (UCSD) launched...
2.
Hill L, Abulhosn K, Yin J, Bamford L
AIDS
. 2023 Feb;
37(4):605-609.
PMID: 36730069
Objective: To describe our experience evaluating and initiating individuals on long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) and evaluate factors associated with starting LAI CAB/RPV and reasons for not starting. Design: We...
3.
Darnell J, Jain S, Sun X, Qin H, Reynolds T, Karris M, et al.
Medicine (Baltimore)
. 2021 Aug;
100(34):e27047.
PMID: 34449491
Evaluate the impact of switching to an anti-retroviral regimen containing tenofovir alafenamide (TAF) on weight and the development of metabolic complications compared to remaining on a non-TAF containing regimen.Single-center retrospective...
4.
Hill L, Martin N, Torriani F, Jain S, Qin H, Mathews W, et al.
Open Forum Infect Dis
. 2021 Feb;
8(2):ofaa643.
PMID: 33553480
Background: Little is known about the risk of hepatitis C virus (HCV) reinfection among people with HIV (PWH) in the direct-acting antiviral (DAA) era. We evaluate HCV reinfection rates in...
5.
Martin T, Hill L, Tang M, Balcombe S
Int J Infect Dis
. 2020 Sep;
100:470-472.
PMID: 32979587
Objectives: Tenofovir alafenamide (TAF) is a preferred nucleotide reverse transcriptase inhibitor used in the treatment of HIV. Co-administration of TAF with rifabutin (RFB) is not recommended due to concerns that...
6.
Hill L, Ballard C, Cachay E
AIDS Rev
. 2019 Dec;
21(4):195-210.
PMID: 31834321
As the HIV epidemic has evolved, so too has the role of the clinical pharmacist (CP) in the management of people living with HIV (PLWH). The modern antiretroviral therapy (ART)...
7.
Hill L, Delmonte R, Andrews B, Richards L, Soto R, Collier S, et al.
Eur J Gastroenterol Hepatol
. 2018 Jul;
30(11):1378-1383.
PMID: 29975243
Background: The availability of direct-acting antivirals (DAA) for the treatment of hepatitis C (HCV) has resulted in the ability to safely and effectively treat patients with cirrhosis and end-stage liver...
8.